Vimnerixin

N/A

Report date: 2024/11/19 20:00:10
NME

Base Information

Drug NameVimnerixin
Drug Alias NameAZD-4721RIST-4721
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 2 antagonists
TargetsC-X-C motif chemokine receptor 2
Therapy Area/IndicationsPalmoplantar pustulosisInflammationFamilial Mediterranean Fever +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAristea Therapeutics Inc
Inactive CompaniesAstrazeneca PlcArena Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPalmoplantar pustulosisInflammationFamilial Mediterranean Fever +[5] 

Other Information

ATC CodeN/A
Related LinksN/A